{
  "sector": "Biotech",
  "stockCount": 8,
  "lastUpdated": "2025-11-25T02:59:56.840Z",
  "stocks": {
    "REGN": {
      "profile": {
        "symbol": "REGN",
        "price": 761.45,
        "marketCap": 78644321041,
        "beta": 0.386,
        "lastDividend": 3.52,
        "range": "476.49-800.99",
        "change": 5.55,
        "changePercentage": 0.73422,
        "volume": 1387049,
        "averageVolume": 1088296,
        "companyName": "Regeneron Pharmaceuticals, Inc.",
        "currency": "USD",
        "cik": "0000872589",
        "isin": "US75886F1075",
        "cusip": "75886F107",
        "exchangeFullName": "NASDAQ Global Select",
        "exchange": "NASDAQ",
        "industry": "Biotechnology",
        "website": "https://www.regeneron.com",
        "description": "Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.",
        "ceo": "Leonard S. Schleifer",
        "sector": "Healthcare",
        "country": "US",
        "fullTimeEmployees": "15158",
        "phone": "914 847 7000",
        "address": "777 Old Saw Mill River Road",
        "city": "Tarrytown",
        "state": "NY",
        "zip": "10591-6707",
        "image": "https://images.financialmodelingprep.com/symbol/REGN.png",
        "ipoDate": "1991-04-02",
        "defaultImage": false,
        "isEtf": false,
        "isActivelyTrading": true,
        "isAdr": false,
        "isFund": false
      },
      "ratios": {
        "symbol": "REGN",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "grossProfitMargin": 0.8612519363469934,
        "ebitMargin": 0.34045204900718207,
        "ebitdaMargin": 0.3744543022109562,
        "operatingProfitMargin": 0.28099563441768766,
        "pretaxProfitMargin": 0.33656527249683144,
        "continuousOperationsProfitMargin": 0.3107027179270525,
        "netProfitMargin": 0.3107027179270525,
        "bottomLineProfitMargin": 0.3107027179270525,
        "receivablesTurnover": 2.286257022811056,
        "payablesTurnover": 2.495883470550982,
        "inventoryTurnover": 0.6382599682570531,
        "fixedAssetTurnover": 3.0875926690871145,
        "assetTurnover": 0.37611826459106873,
        "currentRatio": 4.731105646122252,
        "quickRatio": 3.9483812083259386,
        "solvencyRatio": 0.5823954888291418,
        "cashRatio": 0.6308343685825115,
        "priceToEarningsRatio": 17.418394370665823,
        "priceToEarningsGrowthRatio": 1.6762376920342048,
        "forwardPriceToEarningsGrowthRatio": 1.6762376920342048,
        "priceToBookRatio": 2.6184320492205386,
        "priceToSalesRatio": 5.411942472891142,
        "priceToFreeCashFlowRatio": 20.973750750422965,
        "priceToOperatingCashFlowRatio": 17.387265467707277,
        "debtToAssetsRatio": 0.07162190077172836,
        "debtToEquityRatio": 0.09213179984737818,
        "debtToCapitalRatio": 0.08435959822821136,
        "longTermDebtToCapitalRatio": 0.06332248388537877,
        "financialLeverageRatio": 1.286363512482285,
        "workingCapitalTurnoverRatio": 0.9230349274024775,
        "operatingCashFlowRatio": 1.1207311817052454,
        "operatingCashFlowSalesRatio": 0.3112589776087875,
        "freeCashFlowOperatingCashFlowRatio": 0.8290012442031445,
        "debtServiceCoverageRatio": 89.68659420289855,
        "interestCoverageRatio": 72.29528985507247,
        "shortTermOperatingCashFlowCoverageRatio": 0,
        "operatingCashFlowCoverageRatio": 1.6345584972637184,
        "capitalExpenditureCoverageRatio": 5.8479957666357985,
        "dividendPaidAndCapexCoverageRatio": 5.8479957666357985,
        "dividendPayoutRatio": 0,
        "dividendYield": 0,
        "dividendYieldPercentage": 0,
        "revenuePerShare": 131.6218721037998,
        "netIncomePerShare": 40.895273401297494,
        "interestDebtPerShare": 25.575532900834105,
        "cashPerShare": 83.52641334569046,
        "bookValuePerShare": 272.0444856348471,
        "tangibleBookValuePerShare": 261.3994439295644,
        "shareholdersEquityPerShare": 272.0444856348471,
        "operatingCashFlowPerShare": 40.968489341983314,
        "capexPerShare": 7.005560704355885,
        "freeCashFlowPerShare": 33.962928637627435,
        "netIncomePerEBT": 0.9231573882298792,
        "ebtPerEbit": 1.1977597915152731,
        "priceToFairValue": 2.6184320492205386,
        "debtToMarketCap": 0.025818234347887332,
        "effectiveTaxRate": 0.07684261177012071,
        "enterpriseValueMultiple": 14.493532719067318,
        "dividendPerShare": 0
      },
      "keyMetrics": {
        "symbol": "REGN",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "marketCap": 76860407000,
        "enterpriseValue": 77076607000,
        "evToSales": 5.427165680890015,
        "evToOperatingCashFlow": 17.436173962221467,
        "evToFreeCashFlow": 21.032747639578673,
        "evToEBITDA": 14.493532719067318,
        "netDebtToEBITDA": 0.04065438134637082,
        "currentRatio": 4.731105646122252,
        "incomeQuality": 1.0017903276979558,
        "grahamNumber": 500.3199040518271,
        "grahamNetNet": 63.10727525486562,
        "taxBurden": 0.9231573882298792,
        "interestBurden": 0.9885834832785257,
        "workingCapital": 14716600000,
        "investedCapital": 20464900000,
        "returnOnAssets": 0.11686096707045134,
        "operatingReturnOnAssets": 0.11266862037617378,
        "returnOnTangibleAssets": 0.12052727610431895,
        "returnOnEquity": 0.1503256840728224,
        "returnOnInvestedCapital": 0.10894671875017312,
        "returnOnCapitalEmployed": 0.11801532451478777,
        "earningsYield": 0.05741057291044529,
        "freeCashFlowYield": 0.04767864422055428,
        "capexToOperatingCashFlow": 0.17099875579685556,
        "capexToDepreciation": 1.5653344377717955,
        "capexToRevenue": 0.05322489790170398,
        "salesGeneralAndAdministrativeToRevenue": 0,
        "researchAndDevelopementToRevenue": 0.36846922968595974,
        "stockBasedCompensationToRevenue": 0.06920152091254753,
        "intangiblesToTotalAssets": 0.030418915554802247,
        "averageReceivables": 5939600000,
        "averagePayables": 698050000,
        "averageInventory": 2833900000,
        "daysOfSalesOutstanding": 159.64959160681593,
        "daysOfPayablesOutstanding": 146.2408018269475,
        "daysOfInventoryOutstanding": 571.8672925653387,
        "operatingCycle": 731.5168841721547,
        "cashConversionCycle": 585.2760823452072,
        "freeCashFlowToEquity": 3448400000,
        "freeCashFlowToFirm": 5529758287.830289,
        "tangibleAssetValue": 28205000000,
        "netCurrentAssetValue": 10255100000
      },
      "incomeStatement": {
        "date": "2024-12-31",
        "symbol": "REGN",
        "reportedCurrency": "USD",
        "cik": "0000872589",
        "filingDate": "2025-02-05",
        "acceptedDate": "2025-02-05 09:18:14",
        "fiscalYear": "2024",
        "period": "FY",
        "revenue": 14202000000,
        "costOfRevenue": 1970500000,
        "grossProfit": 12231500000,
        "researchAndDevelopmentExpenses": 5233000000,
        "generalAndAdministrativeExpenses": 0,
        "sellingAndMarketingExpenses": 0,
        "sellingGeneralAndAdministrativeExpenses": 2954400000,
        "otherExpenses": 53400000,
        "operatingExpenses": 8240800000,
        "costAndExpenses": 10211300000,
        "netInterestIncome": 656200000,
        "interestIncome": 711400000,
        "interestExpense": 55200000,
        "depreciationAndAmortization": 482900000,
        "ebitda": 5318000000,
        "ebit": 4835100000,
        "nonOperatingIncomeExcludingInterest": -844400000,
        "operatingIncome": 3990700000,
        "totalOtherIncomeExpensesNet": 789200000,
        "incomeBeforeTax": 4779900000,
        "incomeTaxExpense": 367300000,
        "netIncomeFromContinuingOperations": 4412600000,
        "netIncomeFromDiscontinuedOperations": 0,
        "otherAdjustmentsToNetIncome": 0,
        "netIncome": 4412600000,
        "netIncomeDeductions": 0,
        "bottomLineNetIncome": 4412600000,
        "eps": 40.9,
        "epsDiluted": 38.34,
        "weightedAverageShsOut": 107900000,
        "weightedAverageShsOutDil": 115100000
      },
      "incomeStatementHistory": [
        {
          "date": "2024-12-31",
          "symbol": "REGN",
          "reportedCurrency": "USD",
          "cik": "0000872589",
          "filingDate": "2025-02-05",
          "acceptedDate": "2025-02-05 09:18:14",
          "fiscalYear": "2024",
          "period": "FY",
          "revenue": 14202000000,
          "costOfRevenue": 1970500000,
          "grossProfit": 12231500000,
          "researchAndDevelopmentExpenses": 5233000000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 2954400000,
          "otherExpenses": 53400000,
          "operatingExpenses": 8240800000,
          "costAndExpenses": 10211300000,
          "netInterestIncome": 656200000,
          "interestIncome": 711400000,
          "interestExpense": 55200000,
          "depreciationAndAmortization": 482900000,
          "ebitda": 5318000000,
          "ebit": 4835100000,
          "nonOperatingIncomeExcludingInterest": -844400000,
          "operatingIncome": 3990700000,
          "totalOtherIncomeExpensesNet": 789200000,
          "incomeBeforeTax": 4779900000,
          "incomeTaxExpense": 367300000,
          "netIncomeFromContinuingOperations": 4412600000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": 4412600000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": 4412600000,
          "eps": 40.9,
          "epsDiluted": 38.34,
          "weightedAverageShsOut": 107900000,
          "weightedAverageShsOutDil": 115100000
        },
        {
          "date": "2023-12-31",
          "symbol": "REGN",
          "reportedCurrency": "USD",
          "cik": "0000872589",
          "filingDate": "2024-02-05",
          "acceptedDate": "2024-02-05 09:16:15",
          "fiscalYear": "2023",
          "period": "FY",
          "revenue": 13117200000,
          "costOfRevenue": 2244500000,
          "grossProfit": 10872700000,
          "researchAndDevelopmentExpenses": 3986700000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 2539500000,
          "otherExpenses": -2100000,
          "operatingExpenses": 6524100000,
          "costAndExpenses": 8768600000,
          "netInterestIncome": 422900000,
          "interestIncome": 495900000,
          "interestExpense": 73000000,
          "depreciationAndAmortization": 421000000,
          "ebitda": 4693300000,
          "ebit": 4272300000,
          "nonOperatingIncomeExcludingInterest": 76299999,
          "operatingIncome": 4348600000,
          "totalOtherIncomeExpensesNet": -149300000,
          "incomeBeforeTax": 4199300000,
          "incomeTaxExpense": 245700000,
          "netIncomeFromContinuingOperations": 3953600000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": 3953600000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": 3953600000,
          "eps": 37.05,
          "epsDiluted": 34.77,
          "weightedAverageShsOut": 106700000,
          "weightedAverageShsOutDil": 113700000
        }
      ],
      "analystEstimates": {
        "symbol": "REGN",
        "date": "2029-12-31",
        "revenueLow": 17619340535,
        "revenueHigh": 19416718892,
        "revenueAvg": 18584684800,
        "ebitdaLow": 7924670386,
        "ebitdaHigh": 8733079249,
        "ebitdaAvg": 8358854350,
        "ebitLow": 7432338316,
        "ebitHigh": 8190523562,
        "ebitAvg": 7839547948,
        "netIncomeLow": 6315594604,
        "netIncomeHigh": 7167134338,
        "netIncomeAvg": 6772943307,
        "sgaExpenseLow": 2986135504,
        "sgaExpenseHigh": 3290756174,
        "sgaExpenseAvg": 3149742580,
        "epsAvg": 58.84399,
        "epsHigh": 62.26876,
        "epsLow": 54.8705,
        "numAnalystsRevenue": 10,
        "numAnalystsEps": 6
      },
      "lastUpdated": "2025-11-25T02:59:35.211Z"
    },
    "VRTX": {
      "profile": {
        "symbol": "VRTX",
        "price": 424,
        "marketCap": 108808071440,
        "beta": 0.322,
        "lastDividend": 0,
        "range": "362.5-519.68",
        "change": -2.76,
        "changePercentage": -0.64673,
        "volume": 1926353,
        "averageVolume": 1496423,
        "companyName": "Vertex Pharmaceuticals Incorporated",
        "currency": "USD",
        "cik": "0000875320",
        "isin": "US92532F1003",
        "cusip": "92532F100",
        "exchangeFullName": "NASDAQ Global Select",
        "exchange": "NASDAQ",
        "industry": "Biotechnology",
        "website": "https://www.vrtx.com",
        "description": "Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.",
        "ceo": "Reshma Kewalramani FASN,",
        "sector": "Healthcare",
        "country": "US",
        "fullTimeEmployees": "6100",
        "phone": "617 341 6100",
        "address": "50 Northern Avenue",
        "city": "Boston",
        "state": "MA",
        "zip": "02210",
        "image": "https://images.financialmodelingprep.com/symbol/VRTX.png",
        "ipoDate": "1991-07-24",
        "defaultImage": false,
        "isEtf": false,
        "isActivelyTrading": true,
        "isAdr": false,
        "isFund": false
      },
      "ratios": {
        "symbol": "VRTX",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "grossProfitMargin": 0.8611174127276522,
        "ebitMargin": 0.025326448943294524,
        "ebitdaMargin": 0.044128456184608124,
        "operatingProfitMargin": -0.021134109490839464,
        "pretaxProfitMargin": 0.022549704630629486,
        "continuousOperationsProfitMargin": -0.04860209979945736,
        "netProfitMargin": -0.04860209979945736,
        "bottomLineProfitMargin": -0.04860209979945736,
        "receivablesTurnover": 6.847334410339257,
        "payablesTurnover": 3.705811138014528,
        "inventoryTurnover": 1.2697030031524805,
        "fixedAssetTurnover": 4.263754546158013,
        "assetTurnover": 0.4890605861573145,
        "currentRatio": 2.692139370476351,
        "quickRatio": 2.353980811311227,
        "solvencyRatio": -0.05385720817819583,
        "cashRatio": 1.2819390674970543,
        "priceToEarningsRatio": -193.60576923076923,
        "priceToEarningsGrowthRatio": 1.68639867184892,
        "forwardPriceToEarningsGrowthRatio": 1.68639867184892,
        "priceToBookRatio": 6.319182064157566,
        "priceToSalesRatio": 9.409646917904556,
        "priceToFreeCashFlowRatio": -131.20998355055042,
        "priceToOperatingCashFlowRatio": -210.5059886317499,
        "debtToAssetsRatio": 0.0776409919585323,
        "debtToEquityRatio": 0.10661442082683308,
        "debtToCapitalRatio": 0.09634288042909615,
        "longTermDebtToCapitalRatio": 0,
        "financialLeverageRatio": 1.3731718018720749,
        "workingCapitalTurnoverRatio": 1.3254393033688945,
        "operatingCashFlowRatio": -0.13819222353139202,
        "operatingCashFlowSalesRatio": -0.04470013883721563,
        "freeCashFlowOperatingCashFlowRatio": 1.6043442955745026,
        "debtServiceCoverageRatio": -2.4231082180634664,
        "interestCoverageRatio": -7.611111111111111,
        "shortTermOperatingCashFlowCoverageRatio": -5.336944745395449,
        "operatingCashFlowCoverageRatio": -0.281566161760503,
        "capitalExpenditureCoverageRatio": -1.6546859254282835,
        "dividendPaidAndCapexCoverageRatio": -1.6546859254282835,
        "dividendPayoutRatio": 0,
        "dividendYield": 0,
        "dividendYieldPercentage": 0,
        "revenuePerShare": 42.79650485436893,
        "netIncomePerShare": -2.08,
        "interestDebtPerShare": 6.913009708737864,
        "cashPerShare": 23.75106796116505,
        "bookValuePerShare": 63.726601941747575,
        "tangibleBookValuePerShare": 56.29398058252427,
        "shareholdersEquityPerShare": 63.726601941747575,
        "operatingCashFlowPerShare": -1.9130097087378641,
        "capexPerShare": 1.156116504854369,
        "freeCashFlowPerShare": -3.069126213592233,
        "netIncomePerEBT": -2.1553319919517104,
        "ebtPerEbit": -1.0669815371404037,
        "priceToFairValue": 6.319182064157566,
        "debtToMarketCap": 0.0008901082740048363,
        "effectiveTaxRate": 3.1553319919517104,
        "enterpriseValueMultiple": 207.43399136335594,
        "dividendPerShare": 0
      },
      "keyMetrics": {
        "symbol": "VRTX",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "marketCap": 103695250000,
        "enterpriseValue": 100875150000,
        "evToSales": 9.153741799076233,
        "evToOperatingCashFlow": -204.78105968331303,
        "evToFreeCashFlow": -127.64159180058206,
        "evToEBITDA": 207.43399136335594,
        "netDebtToEBITDA": -5.799095208718898,
        "currentRatio": 2.692139370476351,
        "incomeQuality": 0.9197162061239731,
        "grahamNumber": null,
        "grahamNetNet": 6.998252427184466,
        "taxBurden": -2.1553319919517104,
        "interestBurden": 0.8903618774632748,
        "workingCapital": 6031800000,
        "investedCapital": 10530300000,
        "returnOnAssets": -0.023769371416398913,
        "operatingReturnOnAssets": -0.010290875188342015,
        "returnOnTangibleAssets": -0.025975663577328036,
        "returnOnEquity": -0.032639430577223086,
        "returnOnInvestedCapital": 0.026208509331367782,
        "returnOnCapitalEmployed": -0.012278186054848539,
        "earningsYield": -0.005165135336478769,
        "freeCashFlowYield": -0.007621371277855061,
        "capexToOperatingCashFlow": -0.6043442955745026,
        "capexToDepreciation": 1.4367760617760619,
        "capexToRevenue": 0.02701427391765955,
        "salesGeneralAndAdministrativeToRevenue": 0,
        "researchAndDevelopementToRevenue": 0.32942532281921216,
        "stockBasedCompensationToRevenue": 0.06338417981688006,
        "intangiblesToTotalAssets": 0.08493689311771076,
        "averageReceivables": 1586400000,
        "averagePayables": 388950000,
        "averageInventory": 972100000,
        "daysOfSalesOutstanding": 53.30541465140969,
        "daysOfPayablesOutstanding": 98.49395622345638,
        "daysOfInventoryOutstanding": 287.46880104541,
        "operatingCycle": 340.7742156968197,
        "cashConversionCycle": 242.2802594733633,
        "freeCashFlowToEquity": 2029800000,
        "freeCashFlowToFirm": 3871546841.0462775,
        "tangibleAssetValue": 14495700000,
        "netCurrentAssetValue": 3472800000
      },
      "incomeStatement": {
        "date": "2024-12-31",
        "symbol": "VRTX",
        "reportedCurrency": "USD",
        "cik": "0000875320",
        "filingDate": "2025-02-13",
        "acceptedDate": "2025-02-13 16:01:52",
        "fiscalYear": "2024",
        "period": "FY",
        "revenue": 11020100000,
        "costOfRevenue": 1530500000,
        "grossProfit": 9489600000,
        "researchAndDevelopmentExpenses": 3630300000,
        "generalAndAdministrativeExpenses": 0,
        "sellingAndMarketingExpenses": 0,
        "sellingGeneralAndAdministrativeExpenses": 1464300000,
        "otherExpenses": 4627900000,
        "operatingExpenses": 9722500000,
        "costAndExpenses": 11253000000,
        "netInterestIncome": 567500000,
        "interestIncome": 598100000,
        "interestExpense": 30600000,
        "depreciationAndAmortization": 205800000,
        "ebitda": 486300000,
        "ebit": 279100000,
        "nonOperatingIncomeExcludingInterest": -512000000,
        "operatingIncome": -232900000,
        "totalOtherIncomeExpensesNet": 481400000,
        "incomeBeforeTax": 248500000,
        "incomeTaxExpense": 784100000,
        "netIncomeFromContinuingOperations": -535600000,
        "netIncomeFromDiscontinuedOperations": 0,
        "otherAdjustmentsToNetIncome": 0,
        "netIncome": -535600000,
        "netIncomeDeductions": 0,
        "bottomLineNetIncome": -535600000,
        "eps": -2.08,
        "epsDiluted": -2.08,
        "weightedAverageShsOut": 257500000,
        "weightedAverageShsOutDil": 257900000
      },
      "incomeStatementHistory": [
        {
          "date": "2024-12-31",
          "symbol": "VRTX",
          "reportedCurrency": "USD",
          "cik": "0000875320",
          "filingDate": "2025-02-13",
          "acceptedDate": "2025-02-13 16:01:52",
          "fiscalYear": "2024",
          "period": "FY",
          "revenue": 11020100000,
          "costOfRevenue": 1530500000,
          "grossProfit": 9489600000,
          "researchAndDevelopmentExpenses": 3630300000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 1464300000,
          "otherExpenses": 4627900000,
          "operatingExpenses": 9722500000,
          "costAndExpenses": 11253000000,
          "netInterestIncome": 567500000,
          "interestIncome": 598100000,
          "interestExpense": 30600000,
          "depreciationAndAmortization": 205800000,
          "ebitda": 486300000,
          "ebit": 279100000,
          "nonOperatingIncomeExcludingInterest": -512000000,
          "operatingIncome": -232900000,
          "totalOtherIncomeExpensesNet": 481400000,
          "incomeBeforeTax": 248500000,
          "incomeTaxExpense": 784100000,
          "netIncomeFromContinuingOperations": -535600000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": -535600000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": -535600000,
          "eps": -2.08,
          "epsDiluted": -2.08,
          "weightedAverageShsOut": 257500000,
          "weightedAverageShsOutDil": 257900000
        },
        {
          "date": "2023-12-31",
          "symbol": "VRTX",
          "reportedCurrency": "USD",
          "cik": "0000875320",
          "filingDate": "2024-02-15",
          "acceptedDate": "2024-02-15 16:12:14",
          "fiscalYear": "2023",
          "period": "FY",
          "revenue": 9869200000,
          "costOfRevenue": 1262200000,
          "grossProfit": 8607000000,
          "researchAndDevelopmentExpenses": 3162900000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 1136600000,
          "otherExpenses": 475500000,
          "operatingExpenses": 4775000000,
          "costAndExpenses": 6037200000,
          "netInterestIncome": 570600000,
          "interestIncome": 614700000,
          "interestExpense": 44100000,
          "depreciationAndAmortization": 181300000,
          "ebitda": 4605200000,
          "ebit": 4423900000,
          "nonOperatingIncomeExcludingInterest": -591900000,
          "operatingIncome": 3832000000,
          "totalOtherIncomeExpensesNet": 547800000,
          "incomeBeforeTax": 4379800000,
          "incomeTaxExpense": 760200000,
          "netIncomeFromContinuingOperations": 3619600000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": 3619600000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": 3619600000,
          "eps": 14.05,
          "epsDiluted": 13.89,
          "weightedAverageShsOut": 257700000,
          "weightedAverageShsOutDil": 260500000
        }
      ],
      "analystEstimates": {
        "symbol": "VRTX",
        "date": "2029-12-31",
        "revenueLow": 16094023616,
        "revenueHigh": 17322662868,
        "revenueAvg": 16705088182,
        "ebitdaLow": 6186078000,
        "ebitdaHigh": 6658331454,
        "ebitdaAvg": 6420953576,
        "ebitLow": 5903207521,
        "ebitHigh": 6353866265,
        "ebitAvg": 6127342953,
        "netIncomeLow": 6775471456,
        "netIncomeHigh": 7455641444,
        "netIncomeAvg": 7113753729,
        "sgaExpenseLow": 1895542521,
        "sgaExpenseHigh": 2040250768,
        "sgaExpenseAvg": 1967513266,
        "epsAvg": 27.58338,
        "epsHigh": 28.90904,
        "epsLow": 26.2717,
        "numAnalystsRevenue": 10,
        "numAnalystsEps": 11
      },
      "lastUpdated": "2025-11-25T02:59:36.439Z"
    },
    "LH": {
      "profile": {
        "symbol": "LH",
        "price": 265.31,
        "marketCap": 21994199000,
        "beta": 0.966,
        "lastDividend": 2.88,
        "range": "209.38-293.72",
        "change": -0.33,
        "changePercentage": -0.12423,
        "volume": 913962,
        "averageVolume": 716989,
        "companyName": "Labcorp Holdings Inc.",
        "currency": "USD",
        "cik": "0000920148",
        "isin": "US5049221055",
        "cusip": "504922105",
        "exchangeFullName": "New York Stock Exchange",
        "exchange": "NYSE",
        "industry": "Medical - Equipment & Services",
        "website": "https://www.labcorp.com",
        "description": "Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.",
        "ceo": "Adam H. Schechter",
        "sector": "Healthcare",
        "country": "US",
        "fullTimeEmployees": "60900",
        "phone": "336 229 1127",
        "address": "358 South Main Street",
        "city": "Burlington",
        "state": "NC",
        "zip": "27215",
        "image": "https://images.financialmodelingprep.com/symbol/LH.png",
        "ipoDate": "1990-03-29",
        "defaultImage": false,
        "isEtf": false,
        "isActivelyTrading": true,
        "isAdr": false,
        "isFund": false
      },
      "ratios": {
        "symbol": "LH",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "grossProfitMargin": 0.27860925981443474,
        "ebitMargin": 0.08976931177885909,
        "ebitdaMargin": 0.13923544650201017,
        "operatingProfitMargin": 0.08353511826518768,
        "pretaxProfitMargin": 0.0737571969959028,
        "continuousOperationsProfitMargin": 0.05742991336700259,
        "netProfitMargin": 0.05734535587174934,
        "bottomLineProfitMargin": 0.05734535587174934,
        "receivablesTurnover": 6.203576537911302,
        "payablesTurnover": 10.715345969399406,
        "inventoryTurnover": 19.02777777777778,
        "fixedAssetTurnover": 4.2716556117422995,
        "assetTurnover": 0.7078132651395614,
        "currentRatio": 1.4433067083058075,
        "quickRatio": 1.2952074950453427,
        "solvencyRatio": 0.13473939393939394,
        "cashRatio": 0.45603867635577444,
        "priceToEarningsRatio": 25.790815013404824,
        "priceToEarningsGrowthRatio": 0.3026794915998609,
        "forwardPriceToEarningsGrowthRatio": 0.3026794915998609,
        "priceToBookRatio": 2.3894026477236037,
        "priceToSalesRatio": 1.4789834651661555,
        "priceToFreeCashFlowRatio": 17.55629893238434,
        "priceToOperatingCashFlowRatio": 12.132644721906923,
        "debtToAssetsRatio": 0.3957124979596278,
        "debtToEquityRatio": 0.9032065770845235,
        "debtToCapitalRatio": 0.4745709624796085,
        "longTermDebtToCapitalRatio": 0.39834421746342485,
        "financialLeverageRatio": 2.2824818062144505,
        "workingCapitalTurnoverRatio": 12.902454748326308,
        "operatingCashFlowRatio": 0.47618761635937784,
        "operatingCashFlowSalesRatio": 0.12190115997509397,
        "freeCashFlowOperatingCashFlowRatio": 0.6910707529322739,
        "debtServiceCoverageRatio": 1.322935627999338,
        "interestCoverageRatio": 5.216994719155065,
        "shortTermOperatingCashFlowCoverageRatio": 1.5853244026791962,
        "operatingCashFlowCoverageRatio": 0.21804531954680453,
        "capitalExpenditureCoverageRatio": 3.2369871402327006,
        "dividendPaidAndCapexCoverageRatio": 2.16343792633015,
        "dividendPayoutRatio": 0.32587131367292227,
        "dividendYield": 0.01263516928424131,
        "dividendYieldPercentage": 1.2635169284241308,
        "revenuePerShare": 155.05244338498213,
        "netIncomePerShare": 8.891537544696067,
        "interestDebtPerShare": 89.1668653158522,
        "cashPerShare": 18.10131108462455,
        "bookValuePerShare": 96.14421930870084,
        "tangibleBookValuePerShare": -21.359952324195472,
        "shareholdersEquityPerShare": 95.97377830750894,
        "operatingCashFlowPerShare": 18.90107270560191,
        "capexPerShare": 5.839094159713945,
        "freeCashFlowPerShare": 13.061978545887962,
        "netIncomePerEBT": 0.7774882751433038,
        "ebtPerEbit": 0.8829483758166927,
        "priceToFairValue": 2.3894026477236037,
        "debtToMarketCap": 0.32908093098796315,
        "effectiveTaxRate": 0.22136529442417927,
        "enterpriseValueMultiple": 13.79895544636449,
        "dividendPerShare": 2.897497020262217
      },
      "keyMetrics": {
        "symbol": "LH",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "marketCap": 19239948000,
        "enterpriseValue": 24994048000,
        "evToSales": 1.9213037228359047,
        "evToOperatingCashFlow": 15.761160297641569,
        "evToFreeCashFlow": 22.80686923989415,
        "evToEBITDA": 13.79895544636449,
        "netDebtToEBITDA": 3.1767791089272897,
        "currentRatio": 1.4433067083058075,
        "incomeQuality": 2.1257372654155495,
        "grahamNumber": 138.56577930849284,
        "grahamNetNet": -83.12812872467222,
        "taxBurden": 0.7774882751433038,
        "interestBurden": 0.8216304161671519,
        "workingCapital": 1476300000,
        "investedCapital": 14380300000,
        "returnOnAssets": 0.04058980358017302,
        "operatingReturnOnAssets": 0.06191299591785575,
        "returnOnTangibleAssets": 0.08755457490258674,
        "returnOnEquity": 0.0926454881895631,
        "returnOnInvestedCapital": 0.052103002164389,
        "returnOnCapitalEmployed": 0.07221173781298176,
        "earningsYield": 0.038773493566614636,
        "freeCashFlowYield": 0.05695961340436055,
        "capexToOperatingCashFlow": 0.30892924706772606,
        "capexToDepreciation": 0.7613053613053613,
        "capexToRevenue": 0.03765883356778821,
        "salesGeneralAndAdministrativeToRevenue": 0,
        "researchAndDevelopementToRevenue": 0,
        "stockBasedCompensationToRevenue": 0.00897078154186749,
        "intangiblesToTotalAssets": 0.5364056803961043,
        "averageReceivables": 2097850000,
        "averagePayables": 851650000,
        "averageInventory": 483900000,
        "daysOfSalesOutstanding": 58.83702695846689,
        "daysOfPayablesOutstanding": 34.063295860195,
        "daysOfInventoryOutstanding": 19.182481751824817,
        "operatingCycle": 78.01950871029172,
        "cashConversionCycle": 43.95621285009672,
        "freeCashFlowToEquity": -4658200000,
        "freeCashFlowToFirm": 126789609.17144346,
        "tangibleAssetValue": -1792100000,
        "netCurrentAssetValue": -5506000000
      },
      "incomeStatement": {
        "date": "2024-12-31",
        "symbol": "LH",
        "reportedCurrency": "USD",
        "cik": "0000920148",
        "filingDate": "2025-02-25",
        "acceptedDate": "2025-02-25 12:58:30",
        "fiscalYear": "2024",
        "period": "FY",
        "revenue": 13008900000,
        "costOfRevenue": 9384500000,
        "grossProfit": 3624400000,
        "researchAndDevelopmentExpenses": 0,
        "generalAndAdministrativeExpenses": 0,
        "sellingAndMarketingExpenses": 0,
        "sellingGeneralAndAdministrativeExpenses": 2230000000,
        "otherExpenses": 307700000,
        "operatingExpenses": 2537700000,
        "costAndExpenses": 11922200000,
        "netInterestIncome": -208300000,
        "interestIncome": 0,
        "interestExpense": 208300000,
        "depreciationAndAmortization": 643500000,
        "ebitda": 1811300000,
        "ebit": 1167800000,
        "nonOperatingIncomeExcludingInterest": -81100000,
        "operatingIncome": 1086700000,
        "totalOtherIncomeExpensesNet": -127200000,
        "incomeBeforeTax": 959500000,
        "incomeTaxExpense": 212400000,
        "netIncomeFromContinuingOperations": 747100000,
        "netIncomeFromDiscontinuedOperations": 0,
        "otherAdjustmentsToNetIncome": 0,
        "netIncome": 746000000,
        "netIncomeDeductions": 0,
        "bottomLineNetIncome": 746000000,
        "eps": 8.89,
        "epsDiluted": 8.84,
        "weightedAverageShsOut": 83900000,
        "weightedAverageShsOutDil": 84400000
      },
      "incomeStatementHistory": [
        {
          "date": "2024-12-31",
          "symbol": "LH",
          "reportedCurrency": "USD",
          "cik": "0000920148",
          "filingDate": "2025-02-25",
          "acceptedDate": "2025-02-25 12:58:30",
          "fiscalYear": "2024",
          "period": "FY",
          "revenue": 13008900000,
          "costOfRevenue": 9384500000,
          "grossProfit": 3624400000,
          "researchAndDevelopmentExpenses": 0,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 2230000000,
          "otherExpenses": 307700000,
          "operatingExpenses": 2537700000,
          "costAndExpenses": 11922200000,
          "netInterestIncome": -208300000,
          "interestIncome": 0,
          "interestExpense": 208300000,
          "depreciationAndAmortization": 643500000,
          "ebitda": 1811300000,
          "ebit": 1167800000,
          "nonOperatingIncomeExcludingInterest": -81100000,
          "operatingIncome": 1086700000,
          "totalOtherIncomeExpensesNet": -127200000,
          "incomeBeforeTax": 959500000,
          "incomeTaxExpense": 212400000,
          "netIncomeFromContinuingOperations": 747100000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": 746000000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": 746000000,
          "eps": 8.89,
          "epsDiluted": 8.84,
          "weightedAverageShsOut": 83900000,
          "weightedAverageShsOutDil": 84400000
        },
        {
          "date": "2023-12-31",
          "symbol": "LH",
          "reportedCurrency": "USD",
          "cik": "0000920148",
          "filingDate": "2024-02-26",
          "acceptedDate": "2024-02-26 15:35:03",
          "fiscalYear": "2023",
          "period": "FY",
          "revenue": 12161600000,
          "costOfRevenue": 8796700000,
          "grossProfit": 3364900000,
          "researchAndDevelopmentExpenses": 2000000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 2021400000,
          "otherExpenses": 615900000,
          "operatingExpenses": 2639300000,
          "costAndExpenses": 11436000000,
          "netInterestIncome": -199600000,
          "interestIncome": 0,
          "interestExpense": 199600000,
          "depreciationAndAmortization": 577300000,
          "ebitda": 1349400000,
          "ebit": 768500000,
          "nonOperatingIncomeExcludingInterest": -42900000,
          "operatingIncome": 725600000,
          "totalOtherIncomeExpensesNet": -156700000,
          "incomeBeforeTax": 568900000,
          "incomeTaxExpense": 188500000,
          "netIncomeFromContinuingOperations": 380400000,
          "netIncomeFromDiscontinuedOperations": 38800000,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": 418000000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": 418000000,
          "eps": 4.8,
          "epsDiluted": 4.77,
          "weightedAverageShsOut": 87100000,
          "weightedAverageShsOutDil": 87600000
        }
      ],
      "analystEstimates": {
        "symbol": "LH",
        "date": "2029-12-31",
        "revenueLow": 11953110299,
        "revenueHigh": 12139437591,
        "revenueAvg": 12026159777,
        "ebitdaLow": 2217071201,
        "ebitdaHigh": 2251631316,
        "ebitdaAvg": 2230620469,
        "ebitLow": 1630987725,
        "ebitHigh": 1656411863,
        "ebitAvg": 1640955239,
        "netIncomeLow": 1747518900,
        "netIncomeHigh": 1782996441,
        "netIncomeAvg": 1761428020,
        "sgaExpenseLow": 1812837837,
        "sgaExpenseHigh": 1841096689,
        "sgaExpenseAvg": 1823916699,
        "epsAvg": 20.87,
        "epsHigh": 21.12555,
        "epsLow": 20.7052,
        "numAnalystsRevenue": 9,
        "numAnalystsEps": 6
      },
      "lastUpdated": "2025-11-25T02:58:43.282Z"
    },
    "BNTX": {
      "profile": {
        "symbol": "BNTX",
        "price": 96.54,
        "marketCap": 23213573391,
        "beta": 1.308,
        "lastDividend": 0,
        "range": "81.2-129.27",
        "change": 0.95,
        "changePercentage": 0.99383,
        "volume": 1459483,
        "averageVolume": 935545,
        "companyName": "BioNTech SE",
        "currency": "USD",
        "cik": "0001776985",
        "isin": "US09075V1026",
        "cusip": "09075V102",
        "exchangeFullName": "NASDAQ Global Select",
        "exchange": "NASDAQ",
        "industry": "Biotechnology",
        "website": "https://www.biontech.de",
        "description": "BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, a preclinical stage product for non-small cell lung cancer. It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase 1a/1b clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 to treat solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II clinical trial to treat solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody in Phase II clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.",
        "ceo": "Ugur Sahin",
        "sector": "Healthcare",
        "country": "DE",
        "fullTimeEmployees": "6772",
        "phone": "49 6131 9084 0",
        "address": "An der Goldgrube 12",
        "city": "Mainz",
        "state": null,
        "zip": "55131",
        "image": "https://images.financialmodelingprep.com/symbol/BNTX.png",
        "ipoDate": "2019-10-10",
        "defaultImage": false,
        "isEtf": false,
        "isActivelyTrading": true,
        "isAdr": true,
        "isFund": false
      },
      "ratios": {
        "symbol": "BNTX",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "EUR",
        "grossProfitMargin": 0.8032423394278653,
        "ebitMargin": -0.2417578423176184,
        "ebitdaMargin": -0.13343753407727818,
        "operatingProfitMargin": -0.4777361782559703,
        "pretaxProfitMargin": -0.24633782850496166,
        "continuousOperationsProfitMargin": -0.2418305405110683,
        "netProfitMargin": -0.2418305405110683,
        "bottomLineProfitMargin": -0.2418305405110683,
        "receivablesTurnover": 1.8053021851827549,
        "payablesTurnover": 1.2685727677525194,
        "inventoryTurnover": 1.9106953759265797,
        "fixedAssetTurnover": 2.3247422680412373,
        "assetTurnover": 0.12210992600877953,
        "currentRatio": 7.452243183259354,
        "quickRatio": 7.3399651236525045,
        "solvencyRatio": -0.11777720772141345,
        "cashRatio": 3.8688570069752695,
        "priceToEarningsRatio": -39.76248339996994,
        "priceToEarningsGrowthRatio": 0.23174820897271634,
        "forwardPriceToEarningsGrowthRatio": 0.23174820897271634,
        "priceToBookRatio": 1.362827465007135,
        "priceToSalesRatio": 9.61578285267711,
        "priceToFreeCashFlowRatio": -108.15200411283729,
        "priceToOperatingCashFlowRatio": 127.36629853635051,
        "debtToAssetsRatio": 0.011282884370408837,
        "debtToEquityRatio": 0.013095599940240378,
        "debtToCapitalRatio": 0.012926321998647364,
        "longTermDebtToCapitalRatio": 0.01093968143973749,
        "financialLeverageRatio": 1.160660652925388,
        "workingCapitalTurnoverRatio": 0.16309048495573122,
        "operatingCashFlowRatio": 0.08231610653138871,
        "operatingCashFlowSalesRatio": 0.07549707389771364,
        "freeCashFlowOperatingCashFlowRatio": -1.177660086663457,
        "debtServiceCoverageRatio": -6.735430340354569,
        "interestCoverageRatio": -99.8570334171946,
        "shortTermOperatingCashFlowCoverageRatio": 5.258227848101265,
        "operatingCashFlowCoverageRatio": 0.8170731707317073,
        "capitalExpenditureCoverageRatio": 0.4592084899403051,
        "dividendPaidAndCapexCoverageRatio": 0.4592084899403051,
        "dividendPayoutRatio": 0,
        "dividendYield": 0,
        "dividendYieldPercentage": 0,
        "revenuePerShare": 11.443843594009984,
        "netIncomePerShare": -2.7674708818635607,
        "interestDebtPerShare": 1.1121539808652245,
        "cashPerShare": 69.8153078202995,
        "bookValuePerShare": 80.74500831946756,
        "tangibleBookValuePerShare": 75.87396006655574,
        "shareholdersEquityPerShare": 80.74500831946756,
        "operatingCashFlowPerShare": 0.8639767054908486,
        "capexPerShare": 1.8814475873544094,
        "freeCashFlowPerShare": -1.0174708818635607,
        "netIncomePerEBT": 0.9817028183562048,
        "ebtPerEbit": 0.5156356996119608,
        "priceToFairValue": 1.362827465007135,
        "debtToMarketCap": 0.00960914002431835,
        "effectiveTaxRate": 0.01829718164379519,
        "enterpriseValueMultiple": -46.162572067556525,
        "dividendPerShare": 0
      },
      "keyMetrics": {
        "symbol": "BNTX",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "EUR",
        "marketCap": 26453980206,
        "enterpriseValue": 16946280206,
        "evToSales": 6.159819783359383,
        "evToOperatingCashFlow": 81.59017913336542,
        "evToFreeCashFlow": -69.28160345870809,
        "evToEBITDA": -46.162572067556525,
        "netDebtToEBITDA": 25.899482429855624,
        "currentRatio": 7.452243183259354,
        "incomeQuality": -0.30647779253356944,
        "grahamNumber": null,
        "grahamNetNet": 62.18625207986689,
        "taxBurden": 0.9817028183562048,
        "interestBurden": 1.0189445196211095,
        "workingCapital": 16280300000,
        "investedCapital": 18634700000,
        "returnOnAssets": -0.02952990940846971,
        "operatingReturnOnAssets": -0.05772575544624034,
        "returnOnTangibleAssets": -0.031148899511674398,
        "returnOnEquity": -0.03427420393486201,
        "returnOnInvestedCapital": -0.06436456221518308,
        "returnOnCapitalEmployed": -0.06569364956389173,
        "earningsYield": -0.02514933461124704,
        "freeCashFlowYield": -0.009246245672495155,
        "capexToOperatingCashFlow": 2.177660086663457,
        "capexToDepreciation": 1.5177852348993288,
        "capexToRevenue": 0.1644069644869325,
        "salesGeneralAndAdministrativeToRevenue": 0.19305005270619024,
        "researchAndDevelopementToRevenue": 0.8193813383737414,
        "stockBasedCompensationToRevenue": 0.0366762385954709,
        "intangiblesToTotalAssets": 0.05197583634047502,
        "averageReceivables": 1931800000,
        "averagePayables": 390350000,
        "averageInventory": 320500000,
        "daysOfSalesOutstanding": 202.18221802188216,
        "daysOfPayablesOutstanding": 287.72492148531313,
        "daysOfInventoryOutstanding": 191.02992795122853,
        "operatingCycle": 393.2121459731107,
        "cashConversionCycle": 105.48722448779756,
        "freeCashFlowToEquity": 9428900000,
        "freeCashFlowToFirm": 535069455.51128817,
        "tangibleAssetValue": 18240100000,
        "netCurrentAssetValue": 15684900000
      },
      "incomeStatement": {
        "date": "2024-12-31",
        "symbol": "BNTX",
        "reportedCurrency": "EUR",
        "cik": "0001776985",
        "filingDate": "2025-03-10",
        "acceptedDate": "2025-03-10 07:00:14",
        "fiscalYear": "2024",
        "period": "FY",
        "revenue": 2751100000,
        "costOfRevenue": 541300000,
        "grossProfit": 2209800000,
        "researchAndDevelopmentExpenses": 2254200000,
        "generalAndAdministrativeExpenses": 531100000,
        "sellingAndMarketingExpenses": 67900000,
        "sellingGeneralAndAdministrativeExpenses": 599000000,
        "otherExpenses": 670900000,
        "operatingExpenses": 3524100000,
        "costAndExpenses": 4065400000,
        "netInterestIncome": -13161817,
        "interestIncome": 0,
        "interestExpense": 13161817,
        "depreciationAndAmortization": 298000000,
        "ebitda": -367100000,
        "ebit": -665100000,
        "nonOperatingIncomeExcludingInterest": -649200000,
        "operatingIncome": -1314300000,
        "totalOtherIncomeExpensesNet": 636600000,
        "incomeBeforeTax": -677700000,
        "incomeTaxExpense": -12400000,
        "netIncomeFromContinuingOperations": -665300000,
        "netIncomeFromDiscontinuedOperations": 0,
        "otherAdjustmentsToNetIncome": 0,
        "netIncome": -665300000,
        "netIncomeDeductions": 0,
        "bottomLineNetIncome": -665300000,
        "eps": -2.77,
        "epsDiluted": -2.77,
        "weightedAverageShsOut": 240400000,
        "weightedAverageShsOutDil": 240400000
      },
      "incomeStatementHistory": [
        {
          "date": "2024-12-31",
          "symbol": "BNTX",
          "reportedCurrency": "EUR",
          "cik": "0001776985",
          "filingDate": "2025-03-10",
          "acceptedDate": "2025-03-10 07:00:14",
          "fiscalYear": "2024",
          "period": "FY",
          "revenue": 2751100000,
          "costOfRevenue": 541300000,
          "grossProfit": 2209800000,
          "researchAndDevelopmentExpenses": 2254200000,
          "generalAndAdministrativeExpenses": 531100000,
          "sellingAndMarketingExpenses": 67900000,
          "sellingGeneralAndAdministrativeExpenses": 599000000,
          "otherExpenses": 670900000,
          "operatingExpenses": 3524100000,
          "costAndExpenses": 4065400000,
          "netInterestIncome": -13161817,
          "interestIncome": 0,
          "interestExpense": 13161817,
          "depreciationAndAmortization": 298000000,
          "ebitda": -367100000,
          "ebit": -665100000,
          "nonOperatingIncomeExcludingInterest": -649200000,
          "operatingIncome": -1314300000,
          "totalOtherIncomeExpensesNet": 636600000,
          "incomeBeforeTax": -677700000,
          "incomeTaxExpense": -12400000,
          "netIncomeFromContinuingOperations": -665300000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": -665300000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": -665300000,
          "eps": -2.77,
          "epsDiluted": -2.77,
          "weightedAverageShsOut": 240400000,
          "weightedAverageShsOutDil": 240400000
        },
        {
          "date": "2023-12-31",
          "symbol": "BNTX",
          "reportedCurrency": "EUR",
          "cik": "0001776985",
          "filingDate": "2023-12-31",
          "acceptedDate": "2023-12-30 19:00:00",
          "fiscalYear": "2023",
          "period": "FY",
          "revenue": 3819000000,
          "costOfRevenue": 599800000,
          "grossProfit": 3219200000,
          "researchAndDevelopmentExpenses": 1783100000,
          "generalAndAdministrativeExpenses": 495000000,
          "sellingAndMarketingExpenses": 62700000,
          "sellingGeneralAndAdministrativeExpenses": 557700000,
          "otherExpenses": 188000000,
          "operatingExpenses": 2528800000,
          "costAndExpenses": 3128600000,
          "netInterestIncome": 343548148,
          "interestIncome": 351309173,
          "interestExpense": 7761024,
          "depreciationAndAmortization": 183400000,
          "ebitda": 1377400000,
          "ebit": 1194000000,
          "nonOperatingIncomeExcludingInterest": -503600000,
          "operatingIncome": 690400000,
          "totalOtherIncomeExpensesNet": 495700000,
          "incomeBeforeTax": 1186100000,
          "incomeTaxExpense": 255800000,
          "netIncomeFromContinuingOperations": 930300000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": 930300000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": 930300000,
          "eps": 3.87,
          "epsDiluted": 3.83,
          "weightedAverageShsOut": 240600000,
          "weightedAverageShsOutDil": 242700000
        }
      ],
      "analystEstimates": {
        "symbol": "BNTX",
        "date": "2029-12-31",
        "revenueLow": 2818932134,
        "revenueHigh": 4600280689,
        "revenueAvg": 3756646350,
        "ebitdaLow": 877494596,
        "ebitdaHigh": 1432003771,
        "ebitdaAvg": 1169392066,
        "ebitLow": 737861937,
        "ebitHigh": 1204133999,
        "ebitAvg": 983310780,
        "netIncomeLow": -457490817,
        "netIncomeHigh": -239202808,
        "netIncomeAvg": -354111605,
        "sgaExpenseLow": 359263922,
        "sgaExpenseHigh": 586291122,
        "sgaExpenseAvg": 478772613,
        "epsAvg": -1.47301,
        "epsHigh": -0.99502,
        "epsLow": -1.90304,
        "numAnalystsRevenue": 11,
        "numAnalystsEps": 4
      },
      "lastUpdated": "2025-11-25T02:59:37.604Z"
    },
    "ADMA": {
      "profile": {
        "symbol": "ADMA",
        "price": 18.32,
        "marketCap": 4360119055,
        "beta": 0.448,
        "lastDividend": 0,
        "range": "13.5-25.67",
        "change": 1.14,
        "changePercentage": 6.63562,
        "volume": 5102166,
        "averageVolume": 3508601,
        "companyName": "ADMA Biologics, Inc.",
        "currency": "USD",
        "cik": "0001368514",
        "isin": "US0008991046",
        "cusip": "000899104",
        "exchangeFullName": "NASDAQ Global Market",
        "exchange": "NASDAQ",
        "industry": "Biotechnology",
        "website": "https://www.admabiologics.com",
        "description": "ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.",
        "ceo": "Adam S. Grossman",
        "sector": "Healthcare",
        "country": "US",
        "fullTimeEmployees": "685",
        "phone": "201 478 5552",
        "address": "465 State Route 17",
        "city": "Ramsey",
        "state": "NJ",
        "zip": "07446",
        "image": "https://images.financialmodelingprep.com/symbol/ADMA.png",
        "ipoDate": "2013-10-17",
        "defaultImage": false,
        "isEtf": false,
        "isActivelyTrading": true,
        "isAdr": false,
        "isFund": false
      },
      "ratios": {
        "symbol": "ADMA",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "grossProfitMargin": 0.5148339563000933,
        "ebitMargin": 0.3274538402735113,
        "ebitdaMargin": 0.346318711983004,
        "operatingProfitMargin": 0.32590384894971086,
        "pretaxProfitMargin": 0.29478912145272407,
        "continuousOperationsProfitMargin": 0.4635271330553823,
        "netProfitMargin": 0.4635271330553823,
        "bottomLineProfitMargin": 0.4635271330553823,
        "receivablesTurnover": 8.5292505850117,
        "payablesTurnover": 10.232998664622384,
        "inventoryTurnover": 1.2153846153846153,
        "fixedAssetTurnover": 6.732669203201717,
        "assetTurnover": 0.8726687102754779,
        "currentRatio": 5.966835907961543,
        "quickRatio": 2.901858053365021,
        "solvencyRatio": 1.4729915509093512,
        "cashRatio": 1.857099132188254,
        "priceToEarningsRatio": 20.222238747831014,
        "priceToEarningsGrowthRatio": -0.026825418747122774,
        "forwardPriceToEarningsGrowthRatio": -0.026825418747122774,
        "priceToBookRatio": 11.453250548682302,
        "priceToSalesRatio": 9.373556350743574,
        "priceToFreeCashFlowRatio": 36.30789758122383,
        "priceToOperatingCashFlowRatio": 33.68436193878926,
        "debtToAssetsRatio": 0.1680370305190739,
        "debtToEquityRatio": 0.2352772636368325,
        "debtToCapitalRatio": 0.1904651454072284,
        "longTermDebtToCapitalRatio": 0.17167708939018167,
        "financialLeverageRatio": 1.4001512815957917,
        "workingCapitalTurnoverRatio": 1.7655809139367593,
        "operatingCashFlowRatio": 2.1366173346296495,
        "operatingCashFlowSalesRatio": 0.2782762032950799,
        "freeCashFlowOperatingCashFlowRatio": 0.9277420115949845,
        "debtServiceCoverageRatio": 14.500132030631107,
        "interestCoverageRatio": 9.97724335965542,
        "shortTermOperatingCashFlowCoverageRatio": 97.43185550082102,
        "operatingCashFlowCoverageRatio": 1.4451751181255785,
        "capitalExpenditureCoverageRatio": 13.83930029154519,
        "dividendPaidAndCapexCoverageRatio": 13.83930029154519,
        "dividendPayoutRatio": 0,
        "dividendYield": 0,
        "dividendYieldPercentage": 0,
        "revenuePerShare": 1.8296150743937807,
        "netIncomePerShare": 0.8480762300286592,
        "interestDebtPerShare": 0.4120660362787665,
        "cashPerShare": 0.44253144789003107,
        "bookValuePerShare": 1.4973914983439447,
        "tangibleBookValuePerShare": 1.4802732062260815,
        "shareholdersEquityPerShare": 1.4973914983439447,
        "operatingCashFlowPerShare": 0.5091383363937465,
        "capexPerShare": 0.036789312007688216,
        "freeCashFlowPerShare": 0.47234902438605825,
        "netIncomePerEBT": 1.5724024372782666,
        "ebtPerEbit": 0.9045278919004482,
        "priceToFairValue": 11.453250548682302,
        "debtToMarketCap": 0.018400753731696876,
        "effectiveTaxRate": -0.5724024372782666,
        "enterpriseValueMultiple": 26.923871107530008,
        "dividendPerShare": 0
      },
      "keyMetrics": {
        "symbol": "ADMA",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "marketCap": 3997390599.9999995,
        "enterpriseValue": 3976359599.9999995,
        "evToSales": 9.324240363556209,
        "evToOperatingCashFlow": 33.507142375623566,
        "evToFreeCashFlow": 36.116875119213056,
        "evToEBITDA": 26.923871107530008,
        "netDebtToEBITDA": -0.14240058501310185,
        "currentRatio": 5.966835907961543,
        "incomeQuality": 0.6003450142406904,
        "grahamNumber": 5.345352942307103,
        "grahamNetNet": 0.3694108132690361,
        "taxBurden": 1.5724024372782666,
        "interestBurden": 0.9002463406949099,
        "workingCapital": 275868000,
        "investedCapital": 343199000,
        "returnOnAssets": 0.40450562538113033,
        "operatingReturnOnAssets": 0.3398699043846135,
        "returnOnTangibleAssets": 0.40783555606905886,
        "returnOnEquity": 0.5663690697900968,
        "returnOnInvestedCapital": 0.5031315653596958,
        "returnOnCapitalEmployed": 0.32087612204942556,
        "earningsYield": 0.04945050903957197,
        "freeCashFlowYield": 0.02754221716536783,
        "capexToOperatingCashFlow": 0.0722579884050155,
        "capexToDepreciation": 1.0658794282162833,
        "capexToRevenue": 0.02010767867108762,
        "salesGeneralAndAdministrativeToRevenue": 0,
        "researchAndDevelopementToRevenue": 0.004251337776172811,
        "stockBasedCompensationToRevenue": 0.03192841431901213,
        "intangiblesToTotalAssets": 0.008164885671137231,
        "averageReceivables": 38710000,
        "averagePayables": 17939500,
        "averageInventory": 171570500,
        "daysOfSalesOutstanding": 42.79391212182322,
        "daysOfPayablesOutstanding": 35.66891895157587,
        "daysOfInventoryOutstanding": 300.3164556962025,
        "operatingCycle": 343.11036781802574,
        "cashConversionCycle": 307.4414488664499,
        "freeCashFlowToEquity": 131477000,
        "freeCashFlowToFirm": 150734565.95128626,
        "tangibleAssetValue": 345028000,
        "netCurrentAssetValue": 191750000
      },
      "incomeStatement": {
        "date": "2024-12-31",
        "symbol": "ADMA",
        "reportedCurrency": "USD",
        "cik": "0001368514",
        "filingDate": "2025-03-18",
        "acceptedDate": "2025-03-18 16:12:08",
        "fiscalYear": "2024",
        "period": "FY",
        "revenue": 426454000,
        "costOfRevenue": 206901000,
        "grossProfit": 219553000,
        "researchAndDevelopmentExpenses": 1813000,
        "generalAndAdministrativeExpenses": 0,
        "sellingAndMarketingExpenses": 0,
        "sellingGeneralAndAdministrativeExpenses": 74124000,
        "otherExpenses": 4633000,
        "operatingExpenses": 80570000,
        "costAndExpenses": 287471000,
        "netInterestIncome": -11833000,
        "interestIncome": 2097000,
        "interestExpense": 13930000,
        "depreciationAndAmortization": 8045000,
        "ebitda": 147689000,
        "ebit": 139644000,
        "nonOperatingIncomeExcludingInterest": -661000,
        "operatingIncome": 138983000,
        "totalOtherIncomeExpensesNet": -13269000,
        "incomeBeforeTax": 125714000,
        "incomeTaxExpense": -71959000,
        "netIncomeFromContinuingOperations": 197673000,
        "netIncomeFromDiscontinuedOperations": 0,
        "otherAdjustmentsToNetIncome": 0,
        "netIncome": 197673000,
        "netIncomeDeductions": 0,
        "bottomLineNetIncome": 197673000,
        "eps": 0.85,
        "epsDiluted": 0.81,
        "weightedAverageShsOut": 233084000,
        "weightedAverageShsOutDil": 243342000
      },
      "incomeStatementHistory": [
        {
          "date": "2024-12-31",
          "symbol": "ADMA",
          "reportedCurrency": "USD",
          "cik": "0001368514",
          "filingDate": "2025-03-18",
          "acceptedDate": "2025-03-18 16:12:08",
          "fiscalYear": "2024",
          "period": "FY",
          "revenue": 426454000,
          "costOfRevenue": 206901000,
          "grossProfit": 219553000,
          "researchAndDevelopmentExpenses": 1813000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 74124000,
          "otherExpenses": 4633000,
          "operatingExpenses": 80570000,
          "costAndExpenses": 287471000,
          "netInterestIncome": -11833000,
          "interestIncome": 2097000,
          "interestExpense": 13930000,
          "depreciationAndAmortization": 8045000,
          "ebitda": 147689000,
          "ebit": 139644000,
          "nonOperatingIncomeExcludingInterest": -661000,
          "operatingIncome": 138983000,
          "totalOtherIncomeExpensesNet": -13269000,
          "incomeBeforeTax": 125714000,
          "incomeTaxExpense": -71959000,
          "netIncomeFromContinuingOperations": 197673000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": 197673000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": 197673000,
          "eps": 0.85,
          "epsDiluted": 0.81,
          "weightedAverageShsOut": 233084000,
          "weightedAverageShsOutDil": 243342000
        },
        {
          "date": "2023-12-31",
          "symbol": "ADMA",
          "reportedCurrency": "USD",
          "cik": "0001368514",
          "filingDate": "2024-02-28",
          "acceptedDate": "2024-02-28 17:01:32",
          "fiscalYear": "2023",
          "period": "FY",
          "revenue": 258215000,
          "costOfRevenue": 169273000,
          "grossProfit": 88942000,
          "researchAndDevelopmentExpenses": 3300000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 59020000,
          "otherExpenses": 4990000,
          "operatingExpenses": 67310000,
          "costAndExpenses": 236583000,
          "netInterestIncome": -23410000,
          "interestIncome": 1617000,
          "interestExpense": 25027000,
          "depreciationAndAmortization": 8332000,
          "ebitda": 5120000,
          "ebit": -3212000,
          "nonOperatingIncomeExcludingInterest": 24844000,
          "operatingIncome": 21632000,
          "totalOtherIncomeExpensesNet": -49871000,
          "incomeBeforeTax": -28239000,
          "incomeTaxExpense": 0,
          "netIncomeFromContinuingOperations": -28239000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": -28239000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": -28239000,
          "eps": -0.13,
          "epsDiluted": -0.13,
          "weightedAverageShsOut": 223977315,
          "weightedAverageShsOutDil": 223977315
        }
      ],
      "analystEstimates": {
        "symbol": "ADMA",
        "date": "2029-12-31",
        "revenueLow": 1115612048,
        "revenueHigh": 1121300722,
        "revenueAvg": 1117800000,
        "ebitdaLow": -346761461,
        "ebitdaHigh": -345002242,
        "ebitdaAvg": -345678865,
        "ebitLow": -383808456,
        "ebitHigh": -381861287,
        "ebitAvg": -382610199,
        "netIncomeLow": 487873944,
        "netIncomeHigh": 491107959,
        "netIncomeAvg": 489117422,
        "sgaExpenseLow": 469228189,
        "sgaExpenseHigh": 471620855,
        "sgaExpenseAvg": 470148446,
        "epsAvg": 2.01,
        "epsHigh": 2.01818,
        "epsLow": 2.00489,
        "numAnalystsRevenue": 3,
        "numAnalystsEps": 2
      },
      "lastUpdated": "2025-11-25T02:59:38.805Z"
    },
    "AMGN": {
      "profile": {
        "symbol": "AMGN",
        "price": 334.3,
        "marketCap": 180014088315,
        "beta": 0.461,
        "lastDividend": 9.52,
        "range": "253.3-345.84",
        "change": -3.24,
        "changePercentage": -0.95989,
        "volume": 3453113,
        "averageVolume": 2531564,
        "companyName": "Amgen Inc.",
        "currency": "USD",
        "cik": "0000318154",
        "isin": "US0311621009",
        "cusip": "031162100",
        "exchangeFullName": "NASDAQ Global Select",
        "exchange": "NASDAQ",
        "industry": "Drug Manufacturers - General",
        "website": "https://www.amgen.com",
        "description": "Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.",
        "ceo": "Robert A. Bradway",
        "sector": "Healthcare",
        "country": "US",
        "fullTimeEmployees": "28000",
        "phone": "805 447 1000",
        "address": "One Amgen Center Drive",
        "city": "Thousand Oaks",
        "state": "CA",
        "zip": "91320-1799",
        "image": "https://images.financialmodelingprep.com/symbol/AMGN.png",
        "ipoDate": "1983-06-17",
        "defaultImage": false,
        "isEtf": false,
        "isActivelyTrading": true,
        "isAdr": false,
        "isFund": false
      },
      "ratios": {
        "symbol": "AMGN",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "grossProfitMargin": 0.6153063666826233,
        "ebitMargin": 0.23228817616084252,
        "ebitdaMargin": 0.399593106749641,
        "operatingProfitMargin": 0.21714935375777883,
        "pretaxProfitMargin": 0.13789492580181906,
        "continuousOperationsProfitMargin": 0.12236716132120631,
        "netProfitMargin": 0.12236716132120631,
        "bottomLineProfitMargin": 0.12236716132120631,
        "receivablesTurnover": 4.455939208105586,
        "payablesTurnover": 6.738993710691824,
        "inventoryTurnover": 1.8373821091740496,
        "fixedAssetTurnover": 5.108360079474247,
        "assetTurnover": 0.3639412450048454,
        "currentRatio": 1.256764362093597,
        "quickRatio": 0.953807524135244,
        "solvencyRatio": 0.11263116260673321,
        "cashRatio": 0.5183341270184857,
        "priceToEarningsRatio": 34.47585330073349,
        "priceToEarningsGrowthRatio": -0.8765520596299853,
        "forwardPriceToEarningsGrowthRatio": -0.8765520596299853,
        "priceToBookRatio": 23.992894333843797,
        "priceToSalesRatio": 4.218712302537099,
        "priceToFreeCashFlowRatio": 13.566118914758514,
        "priceToOperatingCashFlowRatio": 12.272083550913838,
        "debtToAssetsRatio": 0.6628883154215529,
        "debtToEquityRatio": 10.358856559469118,
        "debtToCapitalRatio": 0.9119629696207082,
        "longTermDebtToCapitalRatio": 0.9058565341364175,
        "financialLeverageRatio": 15.626850433894845,
        "workingCapitalTurnoverRatio": 3.740585305802697,
        "operatingCashFlowRatio": 0.49742413091475823,
        "operatingCashFlowSalesRatio": 0.34376495931067497,
        "freeCashFlowOperatingCashFlowRatio": 0.9046127067014795,
        "debtServiceCoverageRatio": 1.9145413870246084,
        "interestCoverageRatio": 2.300475435816165,
        "shortTermOperatingCashFlowCoverageRatio": 3.2366197183098593,
        "operatingCashFlowCoverageRatio": 0.18873503178435913,
        "capitalExpenditureCoverageRatio": 10.483576642335766,
        "dividendPaidAndCapexCoverageRatio": 1.938259109311741,
        "dividendPayoutRatio": 1.1814180929095355,
        "dividendYield": 0.03426798700539777,
        "dividendYieldPercentage": 3.4267987005397775,
        "revenuePerShare": 61.781885397412196,
        "netIncomePerShare": 7.56007393715342,
        "interestDebtPerShare": 118.362292051756,
        "cashPerShare": 22.131238447319777,
        "bookValuePerShare": 10.863216266173753,
        "tangibleBookValuePerShare": -74.78558225508318,
        "shareholdersEquityPerShare": 10.863216266173753,
        "operatingCashFlowPerShare": 21.23844731977819,
        "capexPerShare": 2.0258780036968576,
        "freeCashFlowPerShare": 19.212569316081332,
        "netIncomePerEBT": 0.8873942286830115,
        "ebtPerEbit": 0.6350234224304216,
        "priceToFairValue": 23.992894333843797,
        "debtToMarketCap": 0.4262151802643628,
        "effectiveTaxRate": 0.1126057713169885,
        "enterpriseValueMultiple": 14.219245283018868,
        "dividendPerShare": 8.931608133086876
      },
      "keyMetrics": {
        "symbol": "AMGN",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "marketCap": 141006240000,
        "enterpriseValue": 189912240000,
        "evToSales": 5.681912398276688,
        "evToOperatingCashFlow": 16.52848041775457,
        "evToFreeCashFlow": 18.271333461612468,
        "evToEBITDA": 14.219245283018868,
        "netDebtToEBITDA": 3.661725067385445,
        "currentRatio": 1.256764362093597,
        "incomeQuality": 2.8092909535452324,
        "grahamNumber": 42.98663930537172,
        "grahamNetNet": -119.89695009242145,
        "taxBurden": 0.8873942286830115,
        "interestBurden": 0.5936373003606389,
        "workingCapital": 5931000000,
        "investedCapital": 58810000000,
        "returnOnAssets": 0.044534457038948594,
        "operatingReturnOnAssets": 0.07680707751080727,
        "returnOnTangibleAssets": 0.08988418346043119,
        "returnOnEquity": 0.6959332993023651,
        "returnOnInvestedCapital": 0.08896373208532532,
        "returnOnCapitalEmployed": 0.1055862670933954,
        "earningsYield": 0.02900580853726757,
        "freeCashFlowYield": 0.0737130498621905,
        "capexToOperatingCashFlow": 0.09538729329852046,
        "capexToDepreciation": 0.19599427753934193,
        "capexToRevenue": 0.032790808999521304,
        "salesGeneralAndAdministrativeToRevenue": 0.07129607467687889,
        "researchAndDevelopementToRevenue": 0.17843465773097175,
        "stockBasedCompensationToRevenue": 0.015856869315461944,
        "intangiblesToTotalAssets": 0.5045351103561667,
        "averageReceivables": 7721500000,
        "averagePayables": 1749000000,
        "averageInventory": 8258000000,
        "daysOfSalesOutstanding": 81.91314624222116,
        "daysOfPayablesOutstanding": 54.162389174055065,
        "daysOfInventoryOutstanding": 198.65220096438017,
        "operatingCycle": 280.56534720660136,
        "cashConversionCycle": 226.40295803254628,
        "freeCashFlowToEquity": -38512000000,
        "freeCashFlowToFirm": 17394728791.494904,
        "tangibleAssetValue": -40459000000,
        "netCurrentAssetValue": -56932000000
      },
      "incomeStatement": {
        "date": "2024-12-31",
        "symbol": "AMGN",
        "reportedCurrency": "USD",
        "cik": "0000318154",
        "filingDate": "2025-02-14",
        "acceptedDate": "2025-02-14 16:18:41",
        "fiscalYear": "2024",
        "period": "FY",
        "revenue": 33424000000,
        "costOfRevenue": 12858000000,
        "grossProfit": 20566000000,
        "researchAndDevelopmentExpenses": 5964000000,
        "generalAndAdministrativeExpenses": 0,
        "sellingAndMarketingExpenses": 0,
        "sellingGeneralAndAdministrativeExpenses": 7096000000,
        "otherExpenses": 248000000,
        "operatingExpenses": 13308000000,
        "costAndExpenses": 26166000000,
        "netInterestIncome": -3155000000,
        "interestIncome": 0,
        "interestExpense": 3155000000,
        "depreciationAndAmortization": 5592000000,
        "ebitda": 13356000000,
        "ebit": 7764000000,
        "nonOperatingIncomeExcludingInterest": -506000000,
        "operatingIncome": 7258000000,
        "totalOtherIncomeExpensesNet": -2649000000,
        "incomeBeforeTax": 4609000000,
        "incomeTaxExpense": 519000000,
        "netIncomeFromContinuingOperations": 4090000000,
        "netIncomeFromDiscontinuedOperations": 0,
        "otherAdjustmentsToNetIncome": 0,
        "netIncome": 4090000000,
        "netIncomeDeductions": 0,
        "bottomLineNetIncome": 4090000000,
        "eps": 7.62,
        "epsDiluted": 7.56,
        "weightedAverageShsOut": 541000000,
        "weightedAverageShsOutDil": 541000000
      },
      "incomeStatementHistory": [
        {
          "date": "2024-12-31",
          "symbol": "AMGN",
          "reportedCurrency": "USD",
          "cik": "0000318154",
          "filingDate": "2025-02-14",
          "acceptedDate": "2025-02-14 16:18:41",
          "fiscalYear": "2024",
          "period": "FY",
          "revenue": 33424000000,
          "costOfRevenue": 12858000000,
          "grossProfit": 20566000000,
          "researchAndDevelopmentExpenses": 5964000000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 7096000000,
          "otherExpenses": 248000000,
          "operatingExpenses": 13308000000,
          "costAndExpenses": 26166000000,
          "netInterestIncome": -3155000000,
          "interestIncome": 0,
          "interestExpense": 3155000000,
          "depreciationAndAmortization": 5592000000,
          "ebitda": 13356000000,
          "ebit": 7764000000,
          "nonOperatingIncomeExcludingInterest": -506000000,
          "operatingIncome": 7258000000,
          "totalOtherIncomeExpensesNet": -2649000000,
          "incomeBeforeTax": 4609000000,
          "incomeTaxExpense": 519000000,
          "netIncomeFromContinuingOperations": 4090000000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": 4090000000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": 4090000000,
          "eps": 7.62,
          "epsDiluted": 7.56,
          "weightedAverageShsOut": 541000000,
          "weightedAverageShsOutDil": 541000000
        },
        {
          "date": "2023-12-31",
          "symbol": "AMGN",
          "reportedCurrency": "USD",
          "cik": "0000318154",
          "filingDate": "2024-02-14",
          "acceptedDate": "2024-02-14 16:23:32",
          "fiscalYear": "2023",
          "period": "FY",
          "revenue": 28190000000,
          "costOfRevenue": 8415000000,
          "grossProfit": 19775000000,
          "researchAndDevelopmentExpenses": 4784000000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 6179000000,
          "otherExpenses": 879000000,
          "operatingExpenses": 11842000000,
          "costAndExpenses": 20293000000,
          "netInterestIncome": -2875000000,
          "interestIncome": 0,
          "interestExpense": 2875000000,
          "depreciationAndAmortization": 4071000000,
          "ebitda": 14801000000,
          "ebit": 10730000000,
          "nonOperatingIncomeExcludingInterest": -2833000000,
          "operatingIncome": 7897000000,
          "totalOtherIncomeExpensesNet": -42000000,
          "incomeBeforeTax": 7855000000,
          "incomeTaxExpense": 1138000000,
          "netIncomeFromContinuingOperations": 6717000000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": 6717000000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": 6717000000,
          "eps": 12.56,
          "epsDiluted": 12.49,
          "weightedAverageShsOut": 535000000,
          "weightedAverageShsOutDil": 538000000
        }
      ],
      "analystEstimates": {
        "symbol": "AMGN",
        "date": "2029-12-31",
        "revenueLow": 38302593025,
        "revenueHigh": 40158241518,
        "revenueAvg": 39132971019,
        "ebitdaLow": 17871346886,
        "ebitdaHigh": 18737161321,
        "ebitdaAvg": 18258787318,
        "ebitLow": 12402012001,
        "ebitHigh": 13002853173,
        "ebitAvg": 12670880425,
        "netIncomeLow": 12822387093,
        "netIncomeHigh": 13635239595,
        "netIncomeAvg": 13186128444,
        "sgaExpenseLow": 8190438129,
        "sgaExpenseHigh": 8587240877,
        "sgaExpenseAvg": 8368002075,
        "epsAvg": 24.37362,
        "epsHigh": 25.20377,
        "epsLow": 23.70127,
        "numAnalystsRevenue": 12,
        "numAnalystsEps": 10
      },
      "lastUpdated": "2025-11-25T02:58:42.202Z"
    },
    "AXSM": {
      "profile": {
        "symbol": "AXSM",
        "price": 151.2,
        "marketCap": 7622391168,
        "beta": 0.48,
        "lastDividend": 0,
        "range": "75.56-151.385",
        "change": 1.76,
        "changePercentage": 1.17773,
        "volume": 512431,
        "averageVolume": 539359,
        "companyName": "Axsome Therapeutics, Inc.",
        "currency": "USD",
        "cik": "0001579428",
        "isin": "US05464T1043",
        "cusip": "05464T104",
        "exchangeFullName": "NASDAQ Global Market",
        "exchange": "NASDAQ",
        "industry": "Biotechnology",
        "website": "https://www.axsome.com",
        "description": "Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.",
        "ceo": "Herriot Tabuteau",
        "sector": "Healthcare",
        "country": "US",
        "fullTimeEmployees": "712",
        "phone": "212 332 3241",
        "address": "22 Cortlandt Street",
        "city": "New York City",
        "state": "NY",
        "zip": "10007",
        "image": "https://images.financialmodelingprep.com/symbol/AXSM.png",
        "ipoDate": "2015-11-19",
        "defaultImage": false,
        "isEtf": false,
        "isActivelyTrading": true,
        "isAdr": false,
        "isFund": false
      },
      "ratios": {
        "symbol": "AXSM",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "grossProfitMargin": 0.913654123875725,
        "ebitMargin": -0.7274231059417724,
        "ebitdaMargin": -0.7067901154545195,
        "operatingProfitMargin": -0.7274231059417724,
        "pretaxProfitMargin": -0.744454786578963,
        "continuousOperationsProfitMargin": -0.7446751691111843,
        "netProfitMargin": -0.7446751691111843,
        "bottomLineProfitMargin": -0.7446751691111843,
        "receivablesTurnover": 2.716128759656622,
        "payablesTurnover": 0.4625609400391683,
        "inventoryTurnover": 2.116895499618612,
        "fixedAssetTurnover": 71.65019505851755,
        "assetTurnover": 0.6784421405176447,
        "currentRatio": 2.1080207210652575,
        "quickRatio": 2.0396516357820813,
        "solvencyRatio": -0.5459770901476686,
        "cashRatio": 1.370480304557939,
        "priceToEarningsRatio": -14.114824870480755,
        "priceToEarningsGrowthRatio": -1.0331267648254656,
        "forwardPriceToEarningsGrowthRatio": -1.0331267648254656,
        "priceToBookRatio": 71.10415750241165,
        "priceToSalesRatio": 10.510959597400005,
        "priceToFreeCashFlowRatio": -31.504534815045073,
        "priceToOperatingCashFlowRatio": -31.570777509539756,
        "debtToAssetsRatio": 0.33941192405250326,
        "debtToEquityRatio": 3.3842848373235115,
        "debtToCapitalRatio": 0.7719126295155418,
        "longTermDebtToCapitalRatio": 0.7601640551056893,
        "financialLeverageRatio": 9.971025168815224,
        "workingCapitalTurnoverRatio": 1.2434309257877167,
        "operatingCashFlowRatio": -0.5580520112644717,
        "operatingCashFlowSalesRatio": -0.33293318779443754,
        "freeCashFlowOperatingCashFlowRatio": 1.0021026399813098,
        "debtServiceCoverageRatio": -32.4475249881009,
        "interestCoverageRatio": -42.710001522301724,
        "shortTermOperatingCashFlowCoverageRatio": -69.97820163487738,
        "operatingCashFlowCoverageRatio": -0.6654919540825581,
        "capitalExpenditureCoverageRatio": -475.5925925925926,
        "dividendPaidAndCapexCoverageRatio": -475.5925925925926,
        "dividendPayoutRatio": 0,
        "dividendYield": 0,
        "dividendYieldPercentage": 0,
        "revenuePerShare": 8.049693200317234,
        "netIncomePerShare": -5.994406645239387,
        "interestDebtPerShare": 4.164210877822766,
        "cashPerShare": 6.581646282923572,
        "bookValuePerShare": 1.1899444838669282,
        "tangibleBookValuePerShare": -0.04009266602663105,
        "shareholdersEquityPerShare": 1.1899444838669282,
        "operatingCashFlowPerShare": -2.680010017948825,
        "capexPerShare": 0.0056350962140501734,
        "freeCashFlowPerShare": -2.685645114162875,
        "netIncomePerEBT": 1.0002960321247096,
        "ebtPerEbit": 1.0234137196056488,
        "priceToFairValue": 71.10415750241165,
        "debtToMarketCap": 0.04502832772563391,
        "effectiveTaxRate": -0.00029603212470962734,
        "enterpriseValueMultiple": -14.422405907470177,
        "dividendPerShare": 0
      },
      "keyMetrics": {
        "symbol": "AXSM",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "marketCap": 4054003540,
        "enterpriseValue": 3931605540,
        "evToSales": 10.19361393647279,
        "evToOperatingCashFlow": -30.61759629312359,
        "evToFreeCashFlow": -30.553353590301523,
        "evToEBITDA": -14.422405907470177,
        "netDebtToEBITDA": 0.44899561268359967,
        "currentRatio": 2.1080207210652575,
        "incomeQuality": 0.44708512060609434,
        "grahamNumber": null,
        "grahamNetNet": -1.706458446383103,
        "taxBurden": 1.0002960321247096,
        "interestBurden": 1.0234137196056488,
        "workingCapital": 254960000,
        "investedCapital": 319279000,
        "returnOnAssets": -0.5052190157221309,
        "operatingReturnOnAssets": -0.48509337496779725,
        "returnOnTangibleAssets": -0.5636527056570152,
        "returnOnEquity": -5.037551521529422,
        "returnOnInvestedCapital": -0.8170518519439649,
        "returnOnCapitalEmployed": -0.8290986246801066,
        "earningsYield": -0.0708474961025811,
        "freeCashFlowYield": -0.031741462169517495,
        "capexToOperatingCashFlow": -0.002102639981309867,
        "capexToDepreciation": 0,
        "capexToRevenue": 0.0007000386317615305,
        "salesGeneralAndAdministrativeToRevenue": 0.8041603036612021,
        "researchAndDevelopementToRevenue": 0.48504121153352536,
        "stockBasedCompensationToRevenue": 0.2209477485979782,
        "intangiblesToTotalAssets": 0.10366966990209288,
        "averageReceivables": 118410500,
        "averagePayables": 56338000,
        "averageInventory": 15433500,
        "daysOfSalesOutstanding": 134.38243629000266,
        "daysOfPayablesOutstanding": 789.0852175479687,
        "daysOfInventoryOutstanding": 172.4223042969102,
        "operatingCycle": 306.8047405869129,
        "cashConversionCycle": -482.2804769610558,
        "freeCashFlowToEquity": -6282000,
        "freeCashFlowToFirm": -162508055.36497277,
        "tangibleAssetValue": -1921000,
        "netCurrentAssetValue": -26419000
      },
      "incomeStatement": {
        "date": "2024-12-31",
        "symbol": "AXSM",
        "reportedCurrency": "USD",
        "cik": "0001579428",
        "filingDate": "2025-02-18",
        "acceptedDate": "2025-02-18 17:10:58",
        "fiscalYear": "2024",
        "period": "FY",
        "revenue": 385693000,
        "costOfRevenue": 33303000,
        "grossProfit": 352390000,
        "researchAndDevelopmentExpenses": 187077000,
        "generalAndAdministrativeExpenses": 310159000,
        "sellingAndMarketingExpenses": 101200000,
        "sellingGeneralAndAdministrativeExpenses": 411359000,
        "otherExpenses": 34516000,
        "operatingExpenses": 632952000,
        "costAndExpenses": 666255000,
        "netInterestIncome": -6569000,
        "interestIncome": 0,
        "interestExpense": 6569000,
        "depreciationAndAmortization": 7958000,
        "ebitda": -272604000,
        "ebit": -280562000,
        "nonOperatingIncomeExcludingInterest": 0,
        "operatingIncome": -280562000,
        "totalOtherIncomeExpensesNet": -6569000,
        "incomeBeforeTax": -287131000,
        "incomeTaxExpense": 85000,
        "netIncomeFromContinuingOperations": -287216000,
        "netIncomeFromDiscontinuedOperations": 0,
        "otherAdjustmentsToNetIncome": 0,
        "netIncome": -287216000,
        "netIncomeDeductions": 0,
        "bottomLineNetIncome": -287216000,
        "eps": -5.99,
        "epsDiluted": -5.99,
        "weightedAverageShsOut": 47914000,
        "weightedAverageShsOutDil": 47914000
      },
      "incomeStatementHistory": [
        {
          "date": "2024-12-31",
          "symbol": "AXSM",
          "reportedCurrency": "USD",
          "cik": "0001579428",
          "filingDate": "2025-02-18",
          "acceptedDate": "2025-02-18 17:10:58",
          "fiscalYear": "2024",
          "period": "FY",
          "revenue": 385693000,
          "costOfRevenue": 33303000,
          "grossProfit": 352390000,
          "researchAndDevelopmentExpenses": 187077000,
          "generalAndAdministrativeExpenses": 310159000,
          "sellingAndMarketingExpenses": 101200000,
          "sellingGeneralAndAdministrativeExpenses": 411359000,
          "otherExpenses": 34516000,
          "operatingExpenses": 632952000,
          "costAndExpenses": 666255000,
          "netInterestIncome": -6569000,
          "interestIncome": 0,
          "interestExpense": 6569000,
          "depreciationAndAmortization": 7958000,
          "ebitda": -272604000,
          "ebit": -280562000,
          "nonOperatingIncomeExcludingInterest": 0,
          "operatingIncome": -280562000,
          "totalOtherIncomeExpensesNet": -6569000,
          "incomeBeforeTax": -287131000,
          "incomeTaxExpense": 85000,
          "netIncomeFromContinuingOperations": -287216000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": -287216000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": -287216000,
          "eps": -5.99,
          "epsDiluted": -5.99,
          "weightedAverageShsOut": 47914000,
          "weightedAverageShsOutDil": 47914000
        },
        {
          "date": "2023-12-31",
          "symbol": "AXSM",
          "reportedCurrency": "USD",
          "cik": "0001579428",
          "filingDate": "2024-02-23",
          "acceptedDate": "2024-02-23 08:10:48",
          "fiscalYear": "2023",
          "period": "FY",
          "revenue": 270600000,
          "costOfRevenue": 26065000,
          "grossProfit": 244535000,
          "researchAndDevelopmentExpenses": 97944000,
          "generalAndAdministrativeExpenses": 222823000,
          "sellingAndMarketingExpenses": 100300000,
          "sellingGeneralAndAdministrativeExpenses": 323123000,
          "otherExpenses": 55293000,
          "operatingExpenses": 476360000,
          "costAndExpenses": 502425000,
          "netInterestIncome": -6453000,
          "interestIncome": 0,
          "interestExpense": 6453000,
          "depreciationAndAmortization": 6834000,
          "ebitda": -224991000,
          "ebit": -231825000,
          "nonOperatingIncomeExcludingInterest": 0,
          "operatingIncome": -231825000,
          "totalOtherIncomeExpensesNet": -6453000,
          "incomeBeforeTax": -238278000,
          "incomeTaxExpense": 960000,
          "netIncomeFromContinuingOperations": -239238000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": -239238000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": -239238000,
          "eps": -5.27,
          "epsDiluted": -5.27,
          "weightedAverageShsOut": 45425212,
          "weightedAverageShsOutDil": 45425212
        }
      ],
      "analystEstimates": {
        "symbol": "AXSM",
        "date": "2029-12-31",
        "revenueLow": 2387359434,
        "revenueHigh": 2744654419,
        "revenueAvg": 2572468271,
        "ebitdaLow": -295457900,
        "ebitdaHigh": -256995635,
        "ebitdaAvg": -276922321,
        "ebitLow": -320647229,
        "ebitHigh": -278905855,
        "ebitAvg": -300531395,
        "netIncomeLow": 885130672,
        "netIncomeHigh": 1061442218,
        "netIncomeAvg": 976474882,
        "sgaExpenseLow": 3553999076,
        "sgaExpenseHigh": 4085894705,
        "sgaExpenseAvg": 3829565724,
        "epsAvg": 20.37974,
        "epsHigh": 22.15307,
        "epsLow": 18.47332,
        "numAnalystsRevenue": 15,
        "numAnalystsEps": 10
      },
      "lastUpdated": "2025-11-25T02:59:40.005Z"
    },
    "TEM": {
      "profile": {
        "symbol": "TEM",
        "price": 76.06,
        "marketCap": 13041564086,
        "beta": 4.870658,
        "lastDividend": 0,
        "range": "31.36-104.32",
        "change": 5.77,
        "changePercentage": 8.20885,
        "volume": 6104895,
        "averageVolume": 7656004,
        "companyName": "Tempus AI, Inc.",
        "currency": "USD",
        "cik": "0001717115",
        "isin": "US88023B1035",
        "cusip": "71535D106",
        "exchangeFullName": "NASDAQ Global Select",
        "exchange": "NASDAQ",
        "industry": "Medical - Healthcare Information Services",
        "website": "https://www.tempus.com",
        "description": "Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.",
        "ceo": "Eric P. Lefkofsky",
        "sector": "Healthcare",
        "country": "US",
        "fullTimeEmployees": "2400",
        "phone": "800 976 5448",
        "address": "600 West Chicago Avenue",
        "city": "Chicago",
        "state": "IL",
        "zip": "60654",
        "image": "https://images.financialmodelingprep.com/symbol/TEM.png",
        "ipoDate": "2024-06-14",
        "defaultImage": false,
        "isEtf": false,
        "isActivelyTrading": true,
        "isAdr": false,
        "isFund": false
      },
      "ratios": {
        "symbol": "TEM",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "grossProfitMargin": 0.5496309478827456,
        "ebitMargin": -0.9340407673515067,
        "ebitdaMargin": -0.8803270271907332,
        "operatingProfitMargin": -0.9966599269106632,
        "pretaxProfitMargin": -1.0175151932944715,
        "continuousOperationsProfitMargin": -1.0178988113608634,
        "netProfitMargin": -1.0178988113608634,
        "bottomLineProfitMargin": -1.0763371108656212,
        "receivablesTurnover": 4.478765526195105,
        "payablesTurnover": 5.804122370084008,
        "inventoryTurnover": 8.135387901839213,
        "fixedAssetTurnover": 9.522343376637645,
        "assetTurnover": 0.748716143550052,
        "currentRatio": 2.2936166557872677,
        "quickRatio": 2.1617377263201294,
        "solvencyRatio": -0.7686613925178523,
        "cashRatio": 1.1713814546329062,
        "priceToEarningsRatio": -5.732573883302707,
        "priceToEarningsGrowthRatio": -0.020822916075016396,
        "forwardPriceToEarningsGrowthRatio": -0.020822916075016396,
        "priceToBookRatio": 71.81707591544045,
        "priceToSalesRatio": 5.835180141852153,
        "priceToFreeCashFlowRatio": -19.16076565356165,
        "priceToOperatingCashFlowRatio": -21.402852442540134,
        "debtToAssetsRatio": 0.5054377637358604,
        "debtToEquityRatio": 8.30852517794068,
        "debtToCapitalRatio": 0.8925715963717005,
        "longTermDebtToCapitalRatio": 0.8854374459864776,
        "financialLeverageRatio": 16.438275439748665,
        "workingCapitalTurnoverRatio": 2.8059331859006913,
        "operatingCashFlowRatio": -0.6494829422475693,
        "operatingCashFlowSalesRatio": -0.2726356291768941,
        "freeCashFlowOperatingCashFlowRatio": 1.1170144674548388,
        "debtServiceCoverageRatio": -10.159086372105403,
        "interestCoverageRatio": -12.880584496673066,
        "shortTermOperatingCashFlowCoverageRatio": -29.268462610311193,
        "operatingCashFlowCoverageRatio": -0.40386119027374845,
        "capitalExpenditureCoverageRatio": -8.545951810496813,
        "dividendPaidAndCapexCoverageRatio": -6.8134145462408995,
        "dividendPayoutRatio": -0.007969578171998374,
        "dividendYield": 0.00139022685694665,
        "dividendYieldPercentage": 0.139022685694665,
        "revenuePerShare": 5.785596876069054,
        "netIncomePerShare": -5.889152183163814,
        "interestDebtPerShare": 4.353369656818163,
        "cashPerShare": 3.74023145791788,
        "bookValuePerShare": 0.4700831880115812,
        "tangibleBookValuePerShare": -0.2396348738829694,
        "shareholdersEquityPerShare": 0.4700831880115812,
        "operatingCashFlowPerShare": -1.5773598444709593,
        "capexPerShare": 0.18457392218541666,
        "freeCashFlowPerShare": -1.761933766656376,
        "netIncomePerEBT": 1.0003770145830941,
        "ebtPerEbit": 1.0209251579407363,
        "priceToFairValue": 71.81707591544045,
        "debtToMarketCap": 0.10921498612452266,
        "effectiveTaxRate": -0.00037701458309415586,
        "enterpriseValueMultiple": -6.8367071035046525,
        "dividendPerShare": 0.0469340586905189
      },
      "keyMetrics": {
        "symbol": "TEM",
        "date": "2024-12-31",
        "fiscalYear": "2024",
        "period": "FY",
        "reportedCurrency": "USD",
        "marketCap": 4046102239.9999995,
        "enterpriseValue": 4173242239.9999995,
        "evToSales": 6.018538040202019,
        "evToOperatingCashFlow": -22.07539072707556,
        "evToFreeCashFlow": -19.762851216578426,
        "evToEBITDA": -6.8367071035046525,
        "netDebtToEBITDA": -0.20828384530575,
        "currentRatio": 2.2936166557872677,
        "incomeQuality": 0.26784158320452134,
        "grahamNumber": null,
        "grahamNetNet": -2.3880612270440302,
        "taxBurden": 1.0003770145830941,
        "interestBurden": 1.0893691462522117,
        "workingCapital": 376533000,
        "investedCapital": 534410000,
        "returnOnAssets": -0.7621172725662876,
        "operatingReturnOnAssets": -0.9275222659458531,
        "returnOnTangibleAssets": -0.8391928252187426,
        "returnOnEquity": -12.527893643834643,
        "returnOnInvestedCapital": -1.066945922909473,
        "returnOnCapitalEmployed": -1.0882392771547258,
        "earningsYield": -0.17444171158660587,
        "freeCashFlowYield": -0.05218998123982157,
        "capexToOperatingCashFlow": -0.11701446745483879,
        "capexToDepreciation": 0.5939320714189824,
        "capexToRevenue": 0.03190231295734917,
        "salesGeneralAndAdministrativeToRevenue": 0,
        "researchAndDevelopementToRevenue": 0.45694391965364767,
        "stockBasedCompensationToRevenue": 0.7703194990467235,
        "intangiblesToTotalAssets": 0.09184486608588989,
        "averageReceivables": 124640500,
        "averagePayables": 54112500,
        "averageInventory": 33615500,
        "daysOfSalesOutstanding": 81.49567059610786,
        "daysOfPayablesOutstanding": 62.88633780040668,
        "daysOfInventoryOutstanding": 44.86571561234129,
        "operatingCycle": 126.36138620844915,
        "cashConversionCycle": 63.47504840804247,
        "freeCashFlowToEquity": -338306000,
        "freeCashFlowToFirm": -891611178.0189159,
        "tangibleAssetValue": -28720000,
        "netCurrentAssetValue": -202174000
      },
      "incomeStatement": {
        "date": "2024-12-31",
        "symbol": "TEM",
        "reportedCurrency": "USD",
        "cik": "0001717115",
        "filingDate": "2025-02-24",
        "acceptedDate": "2025-02-24 16:05:55",
        "fiscalYear": "2024",
        "period": "FY",
        "revenue": 693398000,
        "costOfRevenue": 312285000,
        "grossProfit": 381113000,
        "researchAndDevelopmentExpenses": 316844000,
        "generalAndAdministrativeExpenses": 0,
        "sellingAndMarketingExpenses": 0,
        "sellingGeneralAndAdministrativeExpenses": 755351000,
        "otherExpenses": 0,
        "operatingExpenses": 1072195000,
        "costAndExpenses": 1384480000,
        "netInterestIncome": -42569000,
        "interestIncome": 11084000,
        "interestExpense": 53653000,
        "depreciationAndAmortization": 37245000,
        "ebitda": -610417000,
        "ebit": -647662000,
        "nonOperatingIncomeExcludingInterest": -43420000,
        "operatingIncome": -691082000,
        "totalOtherIncomeExpensesNet": -14461000,
        "incomeBeforeTax": -705543000,
        "incomeTaxExpense": 266000,
        "netIncomeFromContinuingOperations": -705809000,
        "netIncomeFromDiscontinuedOperations": 0,
        "otherAdjustmentsToNetIncome": 0,
        "netIncome": -705809000,
        "netIncomeDeductions": 0,
        "bottomLineNetIncome": -746330000,
        "eps": -4.6035,
        "epsDiluted": -4.6035,
        "weightedAverageShsOut": 162120761,
        "weightedAverageShsOutDil": 162120761
      },
      "incomeStatementHistory": [
        {
          "date": "2024-12-31",
          "symbol": "TEM",
          "reportedCurrency": "USD",
          "cik": "0001717115",
          "filingDate": "2025-02-24",
          "acceptedDate": "2025-02-24 16:05:55",
          "fiscalYear": "2024",
          "period": "FY",
          "revenue": 693398000,
          "costOfRevenue": 312285000,
          "grossProfit": 381113000,
          "researchAndDevelopmentExpenses": 316844000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 755351000,
          "otherExpenses": 0,
          "operatingExpenses": 1072195000,
          "costAndExpenses": 1384480000,
          "netInterestIncome": -42569000,
          "interestIncome": 11084000,
          "interestExpense": 53653000,
          "depreciationAndAmortization": 37245000,
          "ebitda": -610417000,
          "ebit": -647662000,
          "nonOperatingIncomeExcludingInterest": -43420000,
          "operatingIncome": -691082000,
          "totalOtherIncomeExpensesNet": -14461000,
          "incomeBeforeTax": -705543000,
          "incomeTaxExpense": 266000,
          "netIncomeFromContinuingOperations": -705809000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": -705809000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": -746330000,
          "eps": -4.6035,
          "epsDiluted": -4.6035,
          "weightedAverageShsOut": 162120761,
          "weightedAverageShsOutDil": 162120761
        },
        {
          "date": "2023-12-31",
          "symbol": "TEM",
          "reportedCurrency": "USD",
          "cik": "0001717115",
          "filingDate": "2023-12-31",
          "acceptedDate": "2023-12-30 19:00:00",
          "fiscalYear": "2023",
          "period": "FY",
          "revenue": 531822000,
          "costOfRevenue": 245647000,
          "grossProfit": 286175000,
          "researchAndDevelopmentExpenses": 185498000,
          "generalAndAdministrativeExpenses": 0,
          "sellingAndMarketingExpenses": 0,
          "sellingGeneralAndAdministrativeExpenses": 296760000,
          "otherExpenses": 0,
          "operatingExpenses": 482258000,
          "costAndExpenses": 727905000,
          "netInterestIncome": -39268000,
          "interestIncome": 7601000,
          "interestExpense": 46869000,
          "depreciationAndAmortization": 33332000,
          "ebitda": -133328000,
          "ebit": -166660000,
          "nonOperatingIncomeExcludingInterest": -29423000,
          "operatingIncome": -196083000,
          "totalOtherIncomeExpensesNet": -17747000,
          "incomeBeforeTax": -213830000,
          "incomeTaxExpense": 288000,
          "netIncomeFromContinuingOperations": -214118000,
          "netIncomeFromDiscontinuedOperations": 0,
          "otherAdjustmentsToNetIncome": 0,
          "netIncome": -214118000,
          "netIncomeDeductions": 0,
          "bottomLineNetIncome": -265964000,
          "eps": -1.7251,
          "epsDiluted": -1.7251,
          "weightedAverageShsOut": 154173246,
          "weightedAverageShsOutDil": 154173246
        }
      ],
      "analystEstimates": {
        "symbol": "TEM",
        "date": "2029-12-31",
        "revenueLow": 2785959740,
        "revenueHigh": 2848138718,
        "revenueAvg": 2812587000,
        "ebitdaLow": -2063123232,
        "ebitdaHigh": -2018082275,
        "ebitdaAvg": -2037370422,
        "ebitLow": -2292646683,
        "ebitHigh": -2242594897,
        "ebitAvg": -2264028860,
        "netIncomeLow": 401449915,
        "netIncomeHigh": 413132337,
        "netIncomeAvg": 406452962,
        "sgaExpenseLow": 2141360743,
        "sgaExpenseHigh": 2189153114,
        "sgaExpenseAvg": 2161827144,
        "epsAvg": 2.5071,
        "epsHigh": 2.5483,
        "epsLow": 2.47624,
        "numAnalystsRevenue": 4,
        "numAnalystsEps": 1
      },
      "lastUpdated": "2025-11-25T02:58:44.831Z"
    }
  }
}